Nsaid Induced Duodenal
ulcer

#1

Done By : Aya kamel Ali
SOAP Note
Subjective :
He complains of epigasteric abdominal
pain , vague abdominal discomfort and
dizziness
He noticed darkening of stool one week
ago
the pain come between 1-3 am and
relived by food He describes it of being
moderately to severe
SOAP Note


Subjective , cont



Endoscopy shows multiple gastric ulcer



Manager of stressful job




His father died at age of 59 of shock due to
severe GI bleeding 2ry to untreated PUD
SOAP Note
Objective :
 Hgb 11.0 mg/dL
 Hct 33
 Abd : Mild tenderness , no masses
 Rect : Non-tender ; melenic stool found in
rectal valut ; stool heme +ve
 Endoscopy shows multiple gastric ulcer .

Risk factors :






Nsaid use (ibuprofen)
Age
Smoking
Family history
Stress
Assessment


DRP

Indication (Needs
additional drug therapy )

Untreated condition

A.S 55 year-old African-American male who
suffers from epigastric abdominal pain 1 year
ago which not relieved by using OTC antacid
(Maalox & Bismuth subsalicylate ) needs
additional drug therapy


DRP ,,, cont

Safety (adverse drug
reaction )

Undesirable effect

A.S 55 year-old African-American male who
takes OTC bisthmus subsalicylate for
epigasteric abdominal pain , but his condition
become worse and develops bleeding as a
side effect which increase risk of recuurance
. he needs to stop using it .
Therapeutic goal
Short term goal :
 Prevent complication (perforation , penetration
, obstruction , malignancy
 promote ulcer healing Stop the ulcer bleeding
 Symptomatic relive .
Long term goals :




Preventing recurrence and avoiding potential
complications.
Reduce financial cost of treatment .
Blatchford score

According to blatchford score
Patient has high risk of
bleeding

Pharmacological intervention :


Stop using ibuprofen to prevent further
complication



Stop using bismuth subsalicylate to
minimize the risk of bleeding .
Cont …




Add omeprazole 2o mg Bid
Brand name : Gasec by mepha company
Price 27 SR
Alternatives



Ranitidine double dose 300 mg q.i.d
Endoscopy treatment
Non pharmacological
intervention







Omega -3 fatty acids has anti-inflamatory
effect help to protect the stomach from ulcers
Acupuncture treatments .
Endoscopy treatment .
Injection therapy .
Yoga practice to manage stress
Monitoring


Efficacy



Symptomatic improvement.



Safety



The appearance of adverse events like :
muscle cramps, muscle weakness or limp
feeling; seizures


Monitoring
Testing for H.pylori
 Patients taking the test should stop taking
PPIs for at least 2 weeks (they interfere with
the test) and starve for 4 hours before.
 Fecal Occult Blood Test
CBC & Hemoglobin

Follow up
•
•







Assess the adherence.
Assess the signs and symptoms of progression of
ulcer

Follow up session should be scheduled 2-4
weeks after initiating the therapy.
repeat endoscopy to confirm healing at 6 to 8
weeks.
If ulcer healed decrease omeprazole dose
gradually to maintenance dose to prevent
recurrence.
Patient education :









Take omeprazole 1 hour before meals .
Avoid spicy food and xanthin containing
beverage and , drinks containing caffeine.
Avoid heavy meals before bed time
Smoking increases the amount of acid
produced by the stomach . need smoking
cessation plan .
Encourage small frequent low caloric meals
Avoid ulcerating drug e.g. NSAIDs
,Corticosteroid.
Formal case Presentation (care plan for  patient has duodenal ulcer caused by Nsaid usage )

Formal case Presentation (care plan for patient has duodenal ulcer caused by Nsaid usage )

  • 1.
  • 2.
    SOAP Note Subjective : Hecomplains of epigasteric abdominal pain , vague abdominal discomfort and dizziness He noticed darkening of stool one week ago the pain come between 1-3 am and relived by food He describes it of being moderately to severe
  • 3.
    SOAP Note  Subjective ,cont  Endoscopy shows multiple gastric ulcer  Manager of stressful job   His father died at age of 59 of shock due to severe GI bleeding 2ry to untreated PUD
  • 4.
    SOAP Note Objective : Hgb 11.0 mg/dL  Hct 33  Abd : Mild tenderness , no masses  Rect : Non-tender ; melenic stool found in rectal valut ; stool heme +ve  Endoscopy shows multiple gastric ulcer . 
  • 5.
    Risk factors :      Nsaiduse (ibuprofen) Age Smoking Family history Stress
  • 6.
    Assessment  DRP Indication (Needs additional drugtherapy ) Untreated condition A.S 55 year-old African-American male who suffers from epigastric abdominal pain 1 year ago which not relieved by using OTC antacid (Maalox & Bismuth subsalicylate ) needs additional drug therapy
  • 7.
     DRP ,,, cont Safety(adverse drug reaction ) Undesirable effect A.S 55 year-old African-American male who takes OTC bisthmus subsalicylate for epigasteric abdominal pain , but his condition become worse and develops bleeding as a side effect which increase risk of recuurance . he needs to stop using it .
  • 9.
    Therapeutic goal Short termgoal :  Prevent complication (perforation , penetration , obstruction , malignancy  promote ulcer healing Stop the ulcer bleeding  Symptomatic relive .
  • 10.
    Long term goals:   Preventing recurrence and avoiding potential complications. Reduce financial cost of treatment .
  • 12.
    Blatchford score According toblatchford score Patient has high risk of bleeding 
  • 13.
    Pharmacological intervention :  Stopusing ibuprofen to prevent further complication  Stop using bismuth subsalicylate to minimize the risk of bleeding .
  • 14.
    Cont …    Add omeprazole2o mg Bid Brand name : Gasec by mepha company Price 27 SR
  • 15.
    Alternatives   Ranitidine double dose300 mg q.i.d Endoscopy treatment
  • 16.
    Non pharmacological intervention      Omega -3fatty acids has anti-inflamatory effect help to protect the stomach from ulcers Acupuncture treatments . Endoscopy treatment . Injection therapy . Yoga practice to manage stress
  • 17.
    Monitoring  Efficacy  Symptomatic improvement.  Safety  The appearanceof adverse events like : muscle cramps, muscle weakness or limp feeling; seizures 
  • 18.
    Monitoring Testing for H.pylori Patients taking the test should stop taking PPIs for at least 2 weeks (they interfere with the test) and starve for 4 hours before.  Fecal Occult Blood Test CBC & Hemoglobin 
  • 19.
    Follow up • •    Assess theadherence. Assess the signs and symptoms of progression of ulcer Follow up session should be scheduled 2-4 weeks after initiating the therapy. repeat endoscopy to confirm healing at 6 to 8 weeks. If ulcer healed decrease omeprazole dose gradually to maintenance dose to prevent recurrence.
  • 20.
    Patient education :       Takeomeprazole 1 hour before meals . Avoid spicy food and xanthin containing beverage and , drinks containing caffeine. Avoid heavy meals before bed time Smoking increases the amount of acid produced by the stomach . need smoking cessation plan . Encourage small frequent low caloric meals Avoid ulcerating drug e.g. NSAIDs ,Corticosteroid.